Survival Data and Prognostic Factors in HER2/Neu Positive Metastatic Breast Cancer PatientsUndergoing TDM1: A Single Center Experience


ARIKAN R. , DEMİRCAN N. C. , BAŞOĞLU TÜYLÜ T. , AKIN TELLİ T. , ERCELEP Ö., DANE F. , ...More

3th National Immunotherapy and Oncology Congress, Turkey, 30 October - 03 November 2019

  • Publication Type: Conference Paper / Summary Text
  • Country: Turkey